✦ LIBER ✦

Pharmacokinetics of Teriparatide (rhPTH[1–34]) and Calcium Pharmacodynamics in Postmenopausal Women with Osteoporosis

✍ Scribed by Julie Satterwhite; Michael Heathman; Paul D. Miller; Fernando Marín; Emmett V. Glass; Harald Dobnig

Publisher: Springer
Year: 2010
Tongue: English
Weight: 239 KB
Volume: 87
Category: Article
ISSN: 1432-0827
DOI: 10.1007/s00223-010-9424-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effects of intravenous zoledronic acid p

Effects of intravenous zoledronic acid plus subcutaneous teriparatide [rhPTH(1–34)] in postmenopausal osteoporosis

✍ Felicia Cosman; Erik Fink Eriksen; Chris Recknor; Paul D Miller; Núria Guañabens 📂 Article 📅 2011 🏛 American Society for Bone and Mineral Research 🌐 English ⚖ 204 KB

Effect of raloxifene after recombinant t

Effect of raloxifene after recombinant teriparatide [hPTH(1–34)] treatment in postmenopausal women with osteoporosis

✍ S. Adami; J. San Martin; M. Muñoz-Torres; M. J. Econs; L. Xie; G. P. Dalsky; M. 📂 Article 📅 2007 🏛 Springer-Verlag 🌐 English ⚖ 187 KB

Effects of teriparatide on serum calcium

Effects of teriparatide on serum calcium in postmenopausal women with osteoporosis previously treated with raloxifene or alendronate

✍ R. A. Wermers; C. P. Recknor; F. Cosman; L. Xie; E. V. Glass; J. H. Krege 📂 Article 📅 2008 🏛 Springer-Verlag 🌐 English ⚖ 206 KB

Relationship between duration of teripar

Relationship between duration of teriparatide therapy and clinical outcomes in postmenopausal women with osteoporosis

✍ R. Lindsay; P. Miller; G. Pohl; E. V. Glass; P. Chen; J. H. Krege 📂 Article 📅 2008 🏛 Springer-Verlag 🌐 English ⚖ 127 KB

Effect of teriparatide on bone mineral d

Effect of teriparatide on bone mineral density and biochemical markers in Japanese women with postmenopausal osteoporosis: a 6-month dose-response study

✍ Akimitsu Miyauchi; Toshio Matsumoto; Hirofumi Shigeta; Mika Tsujimoto; Daniel Th 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 313 KB

Effects of 1 year of daily teriparatide

Effects of 1 year of daily teriparatide treatment on iliacal bone mineralization density distribution (BMDD) in postmenopausal osteoporotic women previously treated with alendronate or risedronate

✍ Barbara M Misof; Eleftherios P Paschalis; Stéphane Blouin; Nadja Fratzl-Zelman; 📂 Article 📅 2010 🏛 American Society for Bone and Mineral Research 🌐 English ⚖ 163 KB 👁 1 views

## Abstract Anabolic treatment with teriparatide of postmenopausal osteoporotic patients previously treated with bisphosphonates is a new therapeutic approach. However, its effects on the bone mineralization density distribution (BMDD) are unknown. We studied paired transiliac bone biopsy samples t